Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
dietary supplement
|
| gptkbp:administeredBy |
oral liquid
|
| gptkbp:availableOn |
gptkb:Asia
gptkb:Australia gptkb:Europe |
| gptkbp:compatibleWith |
United States (as medical food)
|
| gptkbp:developedBy |
gptkb:Nutricia
|
| gptkbp:effect |
may slow cognitive decline in early Alzheimer's
supports synaptic function |
| https://www.w3.org/2000/01/rdf-schema#label |
Fortasyn Connect
|
| gptkbp:mainIngredient |
gptkb:choline
gptkb:vitamin_A gptkb:eicosapentaenoic_acid vitamin C folic acid selenium vitamin B12 vitamin B6 docosahexaenoic acid phosphatidylcholine phospholipids uridine monophosphate |
| gptkbp:marketedAs |
gptkb:Souvenaid
|
| gptkbp:mechanismOfAction |
provides precursors for phospholipid synthesis
supports neuronal membrane formation |
| gptkbp:regulates |
medical food (EU)
not approved as drug |
| gptkbp:studiedIn |
LipiDiDiet trial
Souvenir II trial |
| gptkbp:usedFor |
gptkb:Alzheimer's_disease
dietary supplement mild cognitive impairment |
| gptkbp:bfsParent |
gptkb:Souvenaid
|
| gptkbp:bfsLayer |
7
|